Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 728 across all filing types
Latest filing 2023-05-04 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：百济神州有限公司截至2023年3月31日止三个月未经审核业绩以及业务进展最新情况
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from BeiGene, Ltd. regarding its unaudited financial results and business progress for the first quarter ended March 31, 2023. It includes comprehensive financial data such as revenue, costs, net loss, cash position, and detailed operational and R&D updates. The document references the SEC rules and US GAAP accounting standards, and it contains substantive financial statements and analysis for the quarter. The length of the document (over 13,000 characters) and the inclusion of detailed financial tables and business outlook confirm it is a full interim/quarterly financial report rather than a brief earnings release or a simple announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-05-04 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a detailed disclosure report about changes in issued share capital and/or share repurchases by the issuer, as required under the Hong Kong Stock Exchange Listing Rules (Main Board Rule 13.25A and GEM Rule 17.27A). It includes specific data on share issuance dates, share quantities, prices, and percentage changes in issued shares. The document is titled '翌日披露報表' which translates to 'Next Day Disclosure Report' related to share capital changes. It is not an announcement of a report publication but the actual disclosure itself. This fits the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes. The document length is under 5,000 characters but contains substantive data on share issuance and capital changes, so it is not a mere announcement or certification. Therefore, the correct classification is SHA (Share Issue/Capital Change).
2023-05-03 Chinese
百济神州有限公司2023年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is a lengthy communication primarily in Chinese, containing a detailed letter to shareholders, extensive information about the company's business, products, and strategy, and most importantly, a detailed notice and circular for the 2023 Annual General Meeting (AGM) of BeiGene Ltd. It includes the date, time, and location of the AGM, the agenda items for shareholder voting, including director elections, auditor appointments, share issuance and buyback authorizations, executive compensation advisory votes, and amendments to the company's articles of association. The document also references the distribution of proxy forms and voting instructions. The presence of detailed proposals for shareholder approval and the formal notice of the AGM meeting date and procedures clearly identify this document as materials shared for the Annual General Meeting. It is not a full annual report (10-K), nor an earnings release or other financial report. It is not a proxy solicitation statement (PSI) because it is explicitly described as a circular and notice for the AGM. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support a high confidence classification.
2023-04-28 Chinese
百济神州有限公司关于召开2023年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of 百济神州有限公司 (BeiGene Ltd.). It includes information about the date, voting methods, meeting agenda items, and proxy forms for shareholders to vote on various resolutions including board member elections, auditor appointments, share issuance authorizations, and amendments to the company's articles of association. The content is focused on informing shareholders about the AGM logistics and agenda rather than presenting financial results or management analysis. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document length is over 6000 characters and contains detailed meeting and voting information, not just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is AGM Information (AGM-R).
2023-04-28 Chinese
中国国际金融股份有限公司、高盛高华证券有限责任公司关于百济神州有限公司2022年持续督导工作现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022 Year Continuous Supervision On-Site Inspection Report" by joint sponsors for BeiGene Ltd. It details the scope and findings of an on-site inspection covering governance, internal controls, information disclosure, related party transactions, use of raised funds, and operational status during the 2022 calendar year. It references regulatory rules from the Shanghai Stock Exchange and China Securities Regulatory Commission. The document is a detailed report of the inspection results and opinions, not a brief announcement or certification. It is not an annual or quarterly financial report, nor a proxy or voting announcement. The content aligns with an Audit Report / Information type, as it focuses on compliance, internal controls, and regulatory adherence during the supervision period, typical of audit or regulatory inspection reports. The document length is under 5,000 characters but contains substantive content and findings, not just a publication notice. Therefore, the best classification is AR (Audit Report / Information). FY 2022
2023-04-26 Chinese
中国国际金融股份有限公司、高盛高华证券有限责任公司关于百济神州有限公司2022年度持续督导跟踪报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2022年度持续督导跟踪报告" (2022 Annual Continuous Supervision Tracking Report) issued by joint sponsors for a listed company, 百济神州有限公司 (BeiGene Ltd.). It references regulatory frameworks such as the "Securities Issuance and Listing Sponsorship Business Management Measures" and the "Shanghai Stock Exchange STAR Market Listing Rules." The content includes detailed supervisory activities, compliance checks, risk disclosures, financial data, and corrective actions taken during the year 2022. The document is comprehensive, covering the entire fiscal year, with substantive financial data and management oversight information. It is not a brief announcement or a certification letter but a full report on continuous supervision and compliance monitoring by the sponsors. This type of document aligns with an Audit Report / Information (AR) category, as it is a standalone supervisory report related to regulatory compliance and internal controls, distinct from a full Annual Report (10-K) or Interim Report (IR). Therefore, the appropriate classification is AR with high confidence. FY 2022
2023-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.